ENTITY
SMARTSCORE: 3.6/5
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

34
Analysis
Health CareJapan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
bullishSanBio Co Ltd
18 Mar 2025 03:00Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/25 flash update

SanBio reported no operating revenue for FY01/25, with an operating loss of JPY3.5bn, narrowing from JPY4.5bn. Non-operating income was JPY628mn,...

Logo
180 Views
Share
bullishSanBio Co Ltd
16 Dec 2024 10:00Issuer-paid

SanBio Co Ltd (4592 JP): Q3 FY01/25 flash update

In cumulative Q3 FY01/25, SanBio reported no operating revenue, with an operating loss of JPY2.5bn, narrowing YoY. Non-operating income was...

Logo
228 Views
Share
bullishSanBio Co Ltd
17 Sep 2024 10:00Issuer-paid

SanBio Co Ltd (4592 JP): 1H FY01/25 flash update

In 1H FY01/25, the company reported no operating revenue, an operating loss of JPY1.6bn, and R&D expenses of JPY1.0bn. Non-operating income...

Logo
258 Views
Share
x